HA
NXTC icon

HHLR Advisors’s NextCure NXTC Stock Holding History

HHLR Advisors’s Portfolio NXTC Stock Details NXTC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-46,992
Closed -$5.64M – 94
2021
Q1 		$5.64M Sell
46,992
-6,200
-12% -$898K 0.06% 73
2020
Q4 		$6.96M Hold
53,192
– – 0.06% 81
2020
Q3 		$5.62M Hold
53,192
– – 0.04% 76
2020
Q2 		$13.7M Sell
53,192
-34,606
-39% -$13.2M 0.13% 50
2020
Q1 		$39.1M Hold
87,798
– – 0.53% 29
2019
Q4 		$59.3M Hold
87,798
– – 0.74% 24
2019
Q3 		$32.5M Buy
87,798
+81,548
+1,305% +$26.5M 0.45% 32
2019
Q2 		$1.12M Buy
+6,250
New +$1.3M 0.03% 40

Other funds holding NXTC

O
OrbiMed New York $4.59B AUM 125.28% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2B AUM 117.41% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
CPX
Canaan Partners X Menlo Park, California $74.7M AUM 151.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $141B AUM 30.34% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $699M AUM 600.17% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return